Table of Content - Medical Foods Market Size, Trends, Industry Outlook, 2032

Research methodology on Medical Foods Market

1. Introduction

The research methodology serves as a basis for the systematic search for knowledge and the achievement of new insights into the field of medical foods, by utilizing relevant and valid methodologies of data collection and analysis. These methodologies include survey research, secondary research as well as expert interviews, with industrial and health experts who have extensive knowledge and experience in the various aspects of medical food markets.

2. Research objectives

The primary objective of the research study is to investigate and analyze the market size of the medical food market, and to provide a comprehensive assessment of the market impacts and forces on the current and future demand. The study also seeks to assess the impact of government policies and regulations on the market dynamics and identify the factors driving and limiting the growth of the industry. In addition, the research seeks to analyze opportunities and challenges for key players in the industry as a result of the market dynamics and identify key growth strategies deployed by major players in the medical food industry to penetrate the market and stay ahead of the competition.

3. Research design

The research design used is a combination of both qualitative and quantitative research approaches. The qualitative approach is utilized to provide an in-depth understanding of the industry dynamics and subjective views from the market participants. This involves conducting semi-structured interviews with key industry experts and stakeholders, analysing secondary sources and obtaining information on market conditions and trends. The quantitative approach is used for data collection, analysis and estimation of the market size by applying segmentation and regression analysis of the market.

4. Sampling

The sampling method used is a purposive sampling method, in which the sample population is selected based on specific criteria, such as industry size, geographic location, relevancy to the industry and level of expertise. The sample consisted of experts and participants in the medical food industry, including manufacturers, suppliers and distributors, retailers, health professionals and government agencies. The sample size is limited to 20 to provide a representative view of the market with minimal bias.

5. Data collection

Data is collected from both primary and secondary sources. The primary data collection method used is semi-structured interviews and questionnaires which are designed to elicit relevant information from experts and participants in the medical food industry. The secondary data is collected from industry and research journals and reports, and from industry associations, websites and databases.

6. Data analysis

The data collected is analyzed using both descriptive and inferential statistical methods. Descriptive statistical techniques such as frequency analysis, percentage breakdowns, central tendency and dispersal measures are used to analyze the primary data collected from the semi-structured interviews and questionnaires. Inferential techniques such as regression analysis, correlation analysis, chi-squared test, Z test and t-test are used to analyze the secondary data.

7. Validity and reliability

The study is conducted to ensure the validity and reliability of the results obtained by utilizing relevant and valid methodologies of data collection and analysis. The primary data collected via semi-structured interviews and questionnaires are further validated and cross-checked with the secondary data. A pilot survey was conducted at the beginning of the data collection to test the accuracy of the questionnaire. The collected data was validated by interviewing multiple sources of information and by double-checking the responses.

Conclusion

The research methodology served as a guide for the systematic search for knowledge and the achievement of new insights into the medical food market. The research design involves a combination of both qualitative and quantitative approaches which adequately met the research objectives and enabled an effective analysis of the data collected. The data is analyzed using both descriptive and inferential statistical methods and appropriate validity and reliability tests were conducted to ensure that the results obtained were accurate and reliable.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.4 FORECASTING TECHNIQUES

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.5.1 BOTTOM-UP APPROACH

3.5.2 TOP-DOWN APPROACH

3.6 DATA TRIANGULATION

3.7 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES

4.2.2 GROWING NUTRITIONAL DEFICIENCY AMONG PEOPLE

4.2.3 RAISING AWARENESS ABOUT PREBIOTICS AND PROBIOTIC PRODUCTS

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS REGARDING MEDICAL FOOD

4.4 OPPORTUNITIES

4.4.1 INCREASING PRODUCT LAUNCH INITIATIVES AND CONSTANT INNOVATIONS IN DEVELOPING PRODUCTS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL FOODS MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS

6.1 OVERVIEW

6.2 VITAMINS AND MINERALS

6.3 PROTEINS

6.4 OMEGA-3

6.5 ISOFLAVONES

6.6 PHYTOSTEROLS

6.7 OTHERS

7 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION

7.1 OVERVIEW

7.2 ORAL

7.3 ENTERAL

8 GLOBAL MEDICAL FOODS MARKET, BY FORM

8.1 OVERVIEW

8.2 PILLS

8.3 POWDER

8.4 OTHERS

9 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 CHRONIC KIDNEY DISEASE

9.3 NUTRITIONAL DEFICIENCY

9.4 NEUROLOGICAL & PSYCHOLOGICAL DISORDERS

9.5 METABOLIC DISORDERS

9.6 PAIN MANAGEMENT

9.7 GASTROINTESTINAL DISORDERS

9.8 ORPHAN DISEASES

9.9 OTHERS

10 GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 E-COMMERCE

10.3 HOSPITAL PHARMACIES

10.4 RETAIL PHARMACIES

10.5 OTHERS

11 MEDICAL FOODS MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 UK

11.3.3 FRANCE

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 JAPAN

11.4.2 CHINA

11.4.3 INDIA

11.4.4 SOUTH KOREA

11.4.5 AUSTRALIA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL FOODS MARKET

12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL FOODS MARKET

12.5 KEY DEVELOPMENT ANALYSIS

12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

12.6.2 MERGER/ACQUISITION

12.6.3 EXPANSION/ INVESTMENT

12.7 MAJOR PLAYERS SALES ANALYSIS

12.8 MAJOR PLAYERS R&D ANALYSIS

13 COMPANY PROFILES

13.1 DANONE SA

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 PRODUCTS OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 ABBOTT

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 PRODUCTS OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 FRESENIUS KABI AG

13.3.1 COMPANY OVERVIEW

13.3.2 PRODUCTS OFFERED

13.3.3 KEY DEVELOPMENTS

13.3.4 SWOT ANALYSIS

13.3.5 KEY STRATEGIES

13.4 TARGETED MEDICAL PHARMA INC

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 PRODUCTS OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 KEY STRATEGIES

13.5 METAGENICS LLC

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 PRODUCTS OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 KEY STRATEGIES

13.6 NESTLÉ

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 PRODUCTS OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 RECKITT BENCKISER GROUP PLC

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 PRODUCTS OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 SWOT ANALYSIS

13.7.6 KEY STRATEGIES

13.8 MEDTRITION, INC

13.8.1 COMPANY OVERVIEWS

13.8.2 FINANCIAL OVERVIEW

13.8.3 PRODUCTS OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 KEY STRATEGIES

13.9 PRIMUS PHARMACEUTICALS, INC

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 PRODUCTS OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 KEY STRATEGIES

13.10 ALFASIGMA USA, INC

13.10.1 COMPANY OVERVIEW

13.10.2 FINANCIAL OVERVIEW

13.10.3 PRODUCTS OFFERED

13.10.4 KEY DEVELOPMENTSS

13.10.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 3 GLOBAL MEDICAL FOODS MARKET, FOR VITAMINS AND MINERALS, BY REGION, 2019–2030 (USD BILLION)

TABLE 4 GLOBAL MEDICAL FOODS MARKET, FOR PROTEINS, BY REGION, 2019–2030 (USD BILLION)

TABLE 5 GLOBAL MEDICAL FOODS MARKET, FOR OMEGA-3, BY REGION, 2019–2030 (USD BILLION)

TABLE 6 GLOBAL MEDICAL FOODS MARKET, FOR ISOFLAVONES, BY REGION, 2019–2030 (USD BILLION)

TABLE 7 GLOBAL MEDICAL FOODS MARKET, FOR PHYTOSTEROLS, BY REGION, 2019–2030 (USD BILLION)

TABLE 8 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 9 GLOBAL MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 10 GLOBAL MEDICAL FOODS MARKET, FOR ORAL, BY REGION, 2019–2030 (USD BILLION)

TABLE 11 GLOBAL MEDICAL FOODS MARKET, FOR ENTERAL, BY REGION, 2019–2030 (USD BILLION)

TABLE 12 GLOBAL MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 13 GLOBAL MEDICAL FOODS MARKET, FOR PILLS, BY REGION, 2019–2030 (USD BILLION)

TABLE 14 GLOBAL MEDICAL FOODS MARKET, FOR POWDER, BY REGION, 2019–2030 (USD BILLION)

TABLE 15 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 16 GLOBAL MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 17 GLOBAL MEDICAL FOODS MARKET, FOR CHRONIC KIDNEY DISEASE, BY REGION, 2019–2030 (USD BILLION)

TABLE 18 GLOBAL MEDICAL FOODS MARKET, FOR NUTRITIONAL DEFICIENCY, BY REGION, 2019–2030 (USD BILLION)

TABLE 19 GLOBAL MEDICAL FOODS MARKET, FOR NEUROLOGICAL & PSYCHOLOGICAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 20 GLOBAL MEDICAL FOODS MARKET, FOR METABOLIC DISORDERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 21 GLOBAL MEDICAL FOODS MARKET, FOR PAIN MANAGEMENT, BY REGION, 2019–2030 (USD BILLION)

TABLE 22 GLOBAL MEDICAL FOODS MARKET, FOR GASTROINTESTINAL DISORDERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 23 GLOBAL MEDICAL FOODS MARKET, FOR ORPHAN DISEASES, BY REGION, 2019–2030 (USD BILLION)

TABLE 24 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 25 GLOBAL MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 26 GLOBAL MEDICAL FOODS MARKET, FOR E-COMMERCE, BY REGION, 2019–2030 (USD BILLION)

TABLE 27 GLOBAL MEDICAL FOODS MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 28 GLOBAL MEDICAL FOODS MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2030 (USD BILLION)

TABLE 29 GLOBAL MEDICAL FOODS MARKET, FOR OTHERS, BY REGION, 2019–2030 (USD BILLION)

TABLE 30 GLOBAL: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)

TABLE 31 NORTH AMERICA: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 32 NORTH AMERICA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 33 NORTH AMERICA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 34 NORTH AMERICA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 35 NORTH AMERICA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 36 NORTH AMERICA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 37 US: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 38 US: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 39 US: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 40 US: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 41 US: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 42 CANADA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 43 CANADA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 44 CANADA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 45 CANADA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 46 CANADA: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 47 EUROPE: MEDICAL FOODS MARKET, BY REGION, 2019–2030 (USD BILLION)

TABLE 48 EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 49 EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 50 EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 51 EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 52 EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 53 GERMANY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 54 GERMANY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 55 GERMANY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 56 GERMANY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 57 GERMANY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 58 UK: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 59 UK: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 60 UK: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 61 UK: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 62 UK: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 63 FRANCE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 64 FRANCE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 65 FRANCE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 66 FRANCE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 67 FRANCE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 68 ITALY: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 69 ITALY: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 70 ITALY: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 71 ITALY: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 72 ITALY: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 73 SPAIN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 74 SPAIN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 75 SPAIN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 76 SPAIN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 77 SPAIN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 78 REST OF EUROPE: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 79 REST OF EUROPE: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 80 REST OF EUROPE: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 81 REST OF EUROPE: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 82 REST OF EUROPE: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 83 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY COUNTRY, 2019–2030 (USD BILLION)

TABLE 84 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 85 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 86 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 87 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 88 ASIA-PACIFIC: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 89 JAPAN: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 90 JAPAN: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 91 JAPAN: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 92 JAPAN: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

TABLE 93 JAPAN: MEDICAL FOODS MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD BILLION)

TABLE 94 CHINA: MEDICAL FOODS MARKET, BY NUTRITIONAL INGREDIENTS, 2019–2030 (USD BILLION)

TABLE 95 CHINA: MEDICAL FOODS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2030 (USD BILLION)

TABLE 96 CHINA: MEDICAL FOODS MARKET, BY FORM, 2019–2030 (USD BILLION)

TABLE 97 CHINA: MEDICAL FOODS MARKET, BY APPLICATION, 2019–2030 (USD BILLION)

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights